Co-immunoprecipitation analyses showed that both WT Beclin1 and Beclin1 P54A interacted with BCL2, and these bindings were all disrupted in glucose-starved tumor cells (Appendix Fig. S5D,E). This evidence concerns the gene BCL2 and neoplasm.